S. Elissa Altin, MD
Cards
About
Research
Publications
Myocardial infarction with nonobstructive coronary arteries: a single-center retrospective study by sex and race.
Hsueh C, Esin G, Breen T, Gitto M, Katz M, Gulati M, Capers Iv Q, Reynolds H, Volgman A, Wenger N, Altin S. Myocardial infarction with nonobstructive coronary arteries: a single-center retrospective study by sex and race. Coronary Artery Disease 2024 PMID: 38989611, DOI: 10.1097/mca.0000000000001402.Peer-Reviewed Original ResearchRate of nonfatal MINonobstructive coronary arteriesMyocardial infarctionCerebrovascular accidentBlack patientsNonfatal MISecondary outcomesSingle-center retrospective studyCoronary arteryRate of cerebrovascular accidentsIncreased risk of readmissionAssociated with decreased oddsNonfatal cerebrovascular accidentAssociated with increased oddsAcute myocardial infarctionMINOCA patientsPatient-level dataRepeat angiographyCoronary angiographyRisk of readmissionBaseline demographicsRetrospective studyMINOCAFemale sexAngiographic reviewComorbidity Differences Associated with Long-Term Amputation and Repeat Revascularization Rates after Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity
Altin S, Parise H, Hess C, Rosenthal N, Julien H, Curtis J. Comorbidity Differences Associated with Long-Term Amputation and Repeat Revascularization Rates after Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity. The American Journal Of Cardiology 2024 PMID: 38834142, DOI: 10.1016/j.amjcard.2024.05.021.Peer-Reviewed Original ResearchNon-Hispanic patientsHispanic patientsIntermittent claudicationPeripheral vascular interventionsBlack patientsWhite patientsAmputation rateIndex limb amputationHazard ratioCox proportional hazards regression modelsDisease-specific issuesProportional hazards regression modelsHazards regression modelsBaseline characteristicsLimb amputationMajor amputationUnadjusted ratesAssociated with higher ratesHealthcare databasesBlack raceSecondary outcomesPrimary outcomeAmputationRevascularization ratesComparison groupPolyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment
Tannu M, Hess C, Gutierrez J, Lopes R, Swaminathan R, Altin S, Rao S. Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment. Current Cardiology Reports 2024, 26: 505-520. PMID: 38743352, DOI: 10.1007/s11886-024-02063-0.Peer-Reviewed Original ResearchGlobal burdenIncreased riskPolyvascular diseaseIncreased risk of bleedingIncreased risk of adverse outcomesRisk factorsVascular territoriesLow-dose anticoagulationLevels of atherogenic lipoproteinsRisk of adverse outcomesAssociated with increased riskLipid-lowering therapyRisk of bleedingAdverse cardiac eventsType 2 diabetes mellitusHigh-risk subgroupsDose of therapyReview of risk factorsReduce disease progressionPresence of atherosclerosisOptimal timingP2Y12 inhibitorsTreatment intensificationEscalating treatmentIschemic benefitF-12 | Endovascular versus surgical revascularization for patients with chronic limb threatening ischemia: A systematic review and meta-analysis of randomized controlled trials
Balakrishna A, Alla V, Aronow H, Secemsky E, Altin S, Jayasuriya S, Goldsweig A. F-12 | Endovascular versus surgical revascularization for patients with chronic limb threatening ischemia: A systematic review and meta-analysis of randomized controlled trials. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101821. DOI: 10.1016/j.jscai.2024.101821.Peer-Reviewed Original ResearchImpact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis
Jhand A, Abusnina W, Tak H, Ahmed A, Ismayl M, Altin S, Sherwood M, Alexander J, Rao S, Abbott J, Carson J, Goldsweig A. Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis. International Journal Of Cardiology 2024, 408: 132111. PMID: 38697401, DOI: 10.1016/j.ijcard.2024.132111.Peer-Reviewed Original ResearchLength of stayNational Inpatient SampleMyocardial infarctionDiagnosis codesAnemic patientsAdverse eventsPatients admitted with MIAssociated with higher in-hospital mortalityAssociated with high mortalityAssociated with increased mortalityNational database analysisHigher in-hospital mortalityAssociation of anemiaHigher mortalityImpact of anemiaIn-hospital adverse eventsPrimary diagnosis codeSecondary diagnosis codesLonger length of stayMultivariate logistic regressionIn-hospital mortalityIn-hospital outcomesMI hospitalizationConcomitant anemiaBlood transfusionSAFETY AND EFFICACY OF ENDOVASCULAR TREATMENT MODALITIES FOR BELOW-THE-KNEE PERIPHERAL ARTERIAL DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Tirziu D, Saleh A, Huang H, Akhlaghi N, Breen T, Parikh S, Rosenfield K, Armstrong E, Geraghty P, Brodmann M, Adams G, Snyder D, Zilinyi R, Altin S, Parise H, Lansky A. SAFETY AND EFFICACY OF ENDOVASCULAR TREATMENT MODALITIES FOR BELOW-THE-KNEE PERIPHERAL ARTERIAL DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Journal Of The American College Of Cardiology 2024, 83: 843. DOI: 10.1016/s0735-1097(24)02833-x.Peer-Reviewed Original ResearchComparison of Different Durations of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis
Park D, Hu J, Campbell G, Goldwag K, Kelsey M, Altin S, Gallegos-Kattán C, Nanna M. Comparison of Different Durations of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 101859. DOI: 10.1016/j.jscai.2024.101859.Peer-Reviewed Original ResearchMonths of DAPTDuration of dual antiplatelet therapyNet adverse clinical eventsType 2 diabetes mellitusDual antiplatelet therapyAcute coronary syndromeRandomized controlled trialsSensitivity analysis of trialsPercutaneous coronary interventionCoronary interventionNo significant differenceAntiplatelet therapyAnalysis of trialsCoronary syndromeControlled trialsMeta-analysis of patientsStent thrombosisMeta-analysisDAPT durationClinicians greater flexibilityStudy-level meta-analysisOptimal duration of dual antiplatelet therapyHigher risk of adverse eventsPostpercutaneous coronary interventionRisk of adverse eventsAddressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association
Altin S, Kwong M, Hamburg N, Creager M, Banerjee S, Oladini L, Schneider M, Ruddy J, Council O. Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association. Circulation 2024, 149: e986-e995. PMID: 38375663, DOI: 10.1161/cir.0000000000001210.Peer-Reviewed Original ResearchScientific statementMedical school graduatesAmerican Heart AssociationParity of womenAddress barriersPerceived barriersLength of trainingVascular specialtiesCore clerkshipsMedical schoolsVascular interventionsLifestyle considerationsEarly mentorshipHeart AssociationSchool graduatesInterventionWomenSpecialtyRadiation exposureTrainingBarriersWork cultureVascular fieldLifestyleAdvancement of womenSex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study
Nagpal S, Altin S, McGinigle K, Mangalmurti S, Adams G, Shammas N, Mehrle A, Soukas P, Bertolet B, Lansky A. Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study. European Journal Of Vascular And Endovascular Surgery 2024, 67: e22-e23. DOI: 10.1016/j.ejvs.2024.01.026.Peer-Reviewed Original ResearchHypertension Management in Peripheral Artery Disease: A Mini Review
Kharawala A, Nagraj S, Pargaonkar S, Seo J, Kokkinidis D, Altin S. Hypertension Management in Peripheral Artery Disease: A Mini Review. Current Hypertension Reviews 2024, 20: 1-9. PMID: 38083897, DOI: 10.2174/0115734021267004231122061712.Peer-Reviewed Original ResearchPeripheral artery diseaseAngiotensin receptor blockersHypertension managementArtery diseaseAmerican Heart Association/American CollegeDevelopment of PADLower extremity peripheral artery diseaseConcomitant peripheral artery diseaseLower blood pressure levelsBlood pressure targetsGuideline-directed therapyUse of angiotensinLarge randomized trialsBlood pressure levelsTreatment of hypertensionMajor risk factorComplex patient populationWorse health outcomesPost Hoc AnalysisAntihypertensive medicationsHypertensive patientsReceptor blockersPressure targetsRandomized trialsAdequate therapy
Clinical Trials
Current Trials
Women FiRST: Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
HIC ID2000024865REGRolePrincipal InvestigatorPrimary Completion Date04/10/2021Recruiting Participants
Academic Achievements and Community Involvement
Clinical Care
Overview
S. Elissa Altin, MD, is an interventional cardiologist specializing in the care of patients with a variety of cardiovascular and hypertension-related conditions, including atherosclerosis, ventricular tachycardia, hypertensive crisis, and malignant hypertension.
Dr. Altin’s research interests include peripheral artery disease, telemedicine in vascular care, gender representation and disparities in cardiology, quality improvement in percutaneous coronary intervention, and statin therapy in peripheral artery disease.
Dr. Altin was selected as a fellow in the Society for Cardiovascular Angiography and Interventions and the American College of Cardiology Emerging Leader Mentorship Program.
Dr. Altin is an associate professor of medicine at Yale University School of Medicine.
Clinical Specialties
Interventional Cardiology
Links & Media
News
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- July 12, 2023Source: Medscape
Mixed Bag: New Performance Data on Femoral-Popliteal Artery Revascularization
- July 11, 2023Source: TCTMD
Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA
- June 07, 2023
Department of Internal Medicine Promotions and Appointments